SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-23-020609
Filing Date
2023-05-10
Accepted
2023-05-10 16:35:29
Documents
59
Period of Report
2023-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q tnya-20230331.htm   iXBRL 10-Q 2404690
2 EX-10.1 tnya-ex10_1.htm EX-10 62735
3 EX-31.1 tnya-ex31_1.htm EX-31 27341
4 EX-31.2 tnya-ex31_2.htm EX-31 27475
5 EX-32.1 tnya-ex32_1.htm EX-32 18251
  Complete submission text file 0000950170-23-020609.txt   7661546

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT tnya-20230331_lab.xml EX-101.LAB 355810
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT tnya-20230331_def.xml EX-101.DEF 137970
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT tnya-20230331_pre.xml EX-101.PRE 252987
9 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT tnya-20230331.xsd EX-101.SCH 40726
10 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT tnya-20230331_cal.xml EX-101.CAL 42427
53 EXTRACTED XBRL INSTANCE DOCUMENT tnya-20230331_htm.xml XML 1345727
Mailing Address 171 OYSTER POINT BLVD., SUITE 500 SOUTH SAN FRANCISCO CA 94080
Business Address 171 OYSTER POINT BLVD., SUITE 500 SOUTH SAN FRANCISCO CA 94080 415-865-2066
Tenaya Therapeutics, Inc. (Filer) CIK: 0001858848 (see all company filings)

IRS No.: 813789973 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40656 | Film No.: 23907116
SIC: 2836 Biological Products, (No Diagnostic Substances)